netarsudil and latanoprost ophthalmic solution, 0.02%/0.005%

FDA Drug Profile — Rocklatan

netarsudil and latanoprost ophthalmic solution, 0.02%/0.005% is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand name including Rocklatan. Available dosage form: solution/ drops.

Drug details

Generic Name
netarsudil and latanoprost ophthalmic solution, 0.02%/0.005%
Brand Names
Rocklatan
Application Number
NDA208259
Sponsor
Alcon Laboratories, Inc.
NDC Codes
2
Dosage Forms
SOLUTION/ DROPS
Routes
OPHTHALMIC, TOPICAL
Active Ingredients
NETARSUDIL MESYLATE, LATANOPROST

Indications and Usage

1. INDICATIONS AND USAGE ROCKLATAN is a fixed dose combination of a Rho kinase inhibitor and a prostaglandin F 2α analogue indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. ROCKLATAN ® is a fixed dose combination of a Rho kinase inhibitor and a prostaglandin F 2α analogue indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. ( 1 )

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.